Predictive Oncology, a NASDAQ-listed firm, has successfully completed a $343.5 million private investment in public equity (PIPE) financing. The company plans to utilize these funds to acquire ATH tokens on the open market, aligning with its ATH token treasury strategy. ATH serves as the native utility token within the Aethir ecosystem, which is expected to benefit from this strategic investment.
Predictive Oncology Secures $343.5M for ATH Token Acquisition
Disclaimer: The content provided on Phemex News is for informational purposes only. We do not guarantee the quality, accuracy, or completeness of the information sourced from third-party articles. The content on this page does not constitute financial or investment advice. We strongly encourage you to conduct you own research and consult with a qualified financial advisor before making any investment decisions.